Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
122 hedge funds and large institutions have $611M invested in Arena Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 25 closing their positions.
85% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 27
52% more capital invested
Capital invested by funds: $401M → $611M (+$210M)
9% less call options, than puts
Call options by funds: $8.03M | Put options by funds: $8.82M
5% less funds holding
Funds holding: 129 → 122 (-7)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.5M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$34.9M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$25.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.8M |
| 5 |
DM
Deerfield Management
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$10.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.61M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.26M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.05M |
ARNA Hedge Fund Activity: Q1 2015 in Review
122 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2015, worth a combined $611M — up 52% from $401M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ARNA and 18 opened new positions — a net loss of 7 holders — while 27 trimmed existing stakes and 50 added.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $45.5M. The largest seller was Invesco, exiting entirely with an estimated $10.3M sold.
- 122 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2015, down from 129 in Q4 2014.
- Funds reported $611M of Arena Pharmaceuticals Inc stock for Q1 2015, up 52% quarter-over-quarter.
- 18 funds opened new Arena Pharmaceuticals Inc positions in Q1 2015 and 25 closed out, a net change of -7 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2015 was Fidelity Investments, an estimated $45.5M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2015 was Invesco, an estimated $10.3M sold.
Based on aggregated 13F filings for Q1 2015.